Is Gardasil’s recent bad PR helping sales?

March 2, 2007

John Mack thinks so:

It could be — as I said before — that all this attention brought on by the lobbying PR snafu is actually helping sales of Gardasil. Or, maybe we haven’t yet seen the negative effects of bad publicity work its way through the sales cycle yet. But Merck seems optimistic.



Related posts:

  1. Too much Gardasil hype
  2. Gardasil: A "leap of faith"?
  3. Going contrarian on Gardasil
  4. BiDil sales "suck"
  5. Gardasil: New Hampshire shows how it’s done
  6. Pharmaceutical sales reps on MySpace
  7. "Pity the poor pharmaceutical sales rep"


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



{ 1 comment }

1 Anonymous March 2, 2007 at 10:49 am

So it this a good time to buy Merck stock?

Comments on this entry are closed.

Previous post: Insurer restrictions on bariatric care

Next post: Worker’s comp: "The amount of fentanyl prescribed is just stunning"

Site Meter